Capricor Therapeutics
CAPR
#7991
Rank
NZ$0.49 B
Marketcap
NZ$10.94
Share price
-4.36%
Change (1 day)
-57.33%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: NZ$0.49 Billion

As of December 2025 Capricor Therapeutics has a market cap of NZ$0.49 Billion. This makes Capricor Therapeutics the world's 7991th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.49 B-55.96%
2024NZ$1.13 B376.76%
2023NZ$0.23 B55.16%
2022NZ$0.15 B48.14%
2021NZ$0.10 B6.57%
2020NZ$97.2 M878.37%
2019NZ$9.93 M-48.22%
2018NZ$19.18 M-66.46%
2017NZ$57.19 M-30.39%
2016NZ$82.17 M12.57%
2015NZ$72.99 M30.28%
2014NZ$56.03 M21.22%
2013NZ$46.22 M1713.24%
2012NZ$2.54 M-90.81%
2011NZ$27.72 M-0.37%
2010NZ$27.82 M-38.32%
2009NZ$45.12 M27.57%
2008NZ$35.37 M-79.56%
2007NZ$0.17 B3936.66%
2006NZ$4.28 M-40.3%
2005NZ$7.17 M4.4%
2004NZ$6.87 M16.11%
2003NZ$5.92 M-70.67%
2002NZ$20.19 M

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Capricor Therapeutics was reported to be:

NZ$2.54 Billion
by Nasdaq info icon info icon
NZ$0.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Cytokinetics
CYTK
NZ$12.68 B 2,436.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$75 M-85.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$855.65 B 171,037.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$26.68 B 5,236.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$3.22 B 544.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$17.27 M-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA